A WHO analysis of case-based data received over the last three months (21 October 2022 through 30 January 2023) shows that the age and sex distribution, severity and clinical presentation of mpox cases remain unchanged during that period, as the number of reported cases has steadily declined globally. Thirty-nine (39) countries continue to report mpox cases.